Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SynGAP ELISA Kit (AC3388)
Cat.#: ASET-1977
Specifications
Description Human SynGAP ELISA Kit allows for the in vitro quantitative determination of human SynGAP concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2308 Human Gli1 ELISA Kit (AC3719) Quantitative inquiry ASET-1657 Rat Thyroid Hormone Receptor alpha ELISA Kit (AC3068) Quantitative inquiry ASET-1706 Rat Visfatin ELISA Kit (AC3117) Quantitative inquiry ASET-2343 Goat C Peptide ELISA Kit (AC3754) Quantitative inquiry ASET-1671 Human KLC1 ELISA Kit (AC3082) Quantitative inquiry ASET-1976 Human VAT1 ELISA Kit (AC3387) Quantitative inquiry ASET-1261 Rat AKR7A2 ELISA Kit (AC2672) Quantitative inquiry ASET-1548 Human FLJ39155 ELISA Kit (AC2959) Quantitative inquiry ASET-2017 Mouse Somatostatin ELISA Kit (AC3428) Quantitative inquiry ASET-1170 Human LMOD1 ELISA Kit (AC2581) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket